DERMATA THERAPEUTICS INC (DRMA) Stock Income Statement
NASDAQ:DRMA - Nasdaq - US2498454055 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 12.51M | 8.04M | 9.67M | 7.86M | 3.17M | |||
| Research and Development | 8.20M | 4.07M | 5.65M | 3.46M | 1.61M | |||
| Selling, General, and Administrative Expenses | 4.31M | 3.97M | 4.02M | 4.40M | 1.56M | |||
| Operating Income | -12.51M | -8.04M | -9.67M | -7.86M | -3.17M | |||
| Interest Income/Expense | 225.80K | 247.20K | 63.60K | -45.60K | -197.30K | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | 133.60K | |||
| Income Before Taxes | -12.29M | -7.79M | -9.61M | -7.90M | -3.24M | |||
| Net Income | -12.29M | -7.79M | -9.61M | -10.46M | -3.24M | |||
| EBITDA | N/A | N/A | N/A | N/A | -3.17M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -8.03 | -39.98 | -208.93 | -301.57 | -93.26 | |||
| Non GAAP EPS | -15.33 | -54.75 | -220.80 | N/A | N/A | |||
| Statistics | ||||||||
All data in USD